List of Excipients in API GANCICLOVIR SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GANCICLOVIR SODIUM
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
H2-Pharma LLC | CYTOVENE | ganciclovir sodium | 61269-450 | HYDROCHLORIC ACID | |
H2-Pharma LLC | CYTOVENE | ganciclovir sodium | 61269-450 | SODIUM HYDROXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing GANCICLOVIR SODIUM
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | ganciclovir sodium | 0143-9299 | WATER |
Hainan Poly Pharm Co Ltd | ganciclovir sodium | 14335-030 | HYDROCHLORIC ACID |
Hainan Poly Pharm Co Ltd | ganciclovir sodium | 14335-030 | SODIUM HYDROXIDE |
Sagent Pharmaceuticals | ganciclovir sodium | 25021-185 | HYDROCHLORIC ACID |
Sagent Pharmaceuticals | ganciclovir sodium | 25021-185 | SODIUM HYDROXIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for GANCICLOVIR SODIUM
Excipient focus: HYDROCHLORIC ACID
GANCICLOVIR SODIUM drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hainan Poly Pharm Co Ltd | ganciclovir sodium | 14335-030 |
Sagent Pharmaceuticals | ganciclovir sodium | 25021-185 |
Pharmascience Inc | ganciclovir sodium | 51817-171 |
H2-Pharma LLC | ganciclovir sodium | 61269-450 |
Fresenius Kabi USA LLC | ganciclovir sodium | 63323-315 |
>Company | >Ingredient | >NDC |
GANCICLOVIR SODIUM drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | ganciclovir sodium | 0143-9299 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
GANCICLOVIR SODIUM drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hainan Poly Pharm Co Ltd | ganciclovir sodium | 14335-030 |
Sagent Pharmaceuticals | ganciclovir sodium | 25021-185 |
Pharmascience Inc | ganciclovir sodium | 51817-171 |
H2-Pharma LLC | ganciclovir sodium | 61269-450 |
Fresenius Kabi USA LLC | ganciclovir sodium | 63323-315 |
>Company | >Ingredient | >NDC |
GANCICLOVIR SODIUM drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | ganciclovir sodium | 0143-9299 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
GANCICLOVIR SODIUM drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | ganciclovir sodium | 0143-9299 |
Pharmascience Inc | ganciclovir sodium | 51817-171 |
>Company | >Ingredient | >NDC |
GANCICLOVIR SODIUM drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Hainan Poly Pharm Co Ltd | ganciclovir sodium | 14335-030 |
Sagent Pharmaceuticals | ganciclovir sodium | 25021-185 |
H2-Pharma LLC | ganciclovir sodium | 61269-450 |
Fresenius Kabi USA LLC | ganciclovir sodium | 63323-315 |
Slate Run Pharmaceuticals LLC | ganciclovir sodium | 70436-089 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.